Fundus Imaging Market to Generate $865 Million in 2016

June 9, 2016: By Market Scope

The fundus imaging market will generate $865 million in total end-user revenues during 2016, and the market will grow to nearly $1.1 billion by 2021 at a compound annual growth rate of 4.2 percent, according to Market Scope estimates.

Much of this growth will come from demand for newer, more featured devices to replace those currently in use and expansion of eye care services in developing markets. The most growth will occur in the advanced fundus imaging market as technology advances and demands for long-term patient monitoring grow.

Heidelberg is the market leader in this segment, capturing an estimated 24 percent of fundus imaging system revenues. The company produces popular advanced imaging units that are modular and offers a wide variety of configurations. Other market leaders include Optos, Topcon, Carl Zeiss Meditec, Nidek, and Kowa.

Fundus imaging systems are employed by eye care professionals as a tool to help diagnose, stage, and treat glaucomatous and retinal conditions. The retinal diagnostic market as a whole is a $1.4 billion market, of which fundus imaging devices play a large role. Technology ranges widely from basic screeners to advanced and combination units.

Market Scope’s new report on fundus imaging divides the market into four segments: fundus imaging screeners, diagnostic fundus imaging, advanced fundus Imaging systems, and combination imaging systems. The report analyzes each segment, as well as leading models and their current features.

Combination imaging systems, which merge the benefits of OCT/SLO and OCT/fundus imaging, account for the largest segment. Screening fundus imaging systems are also a popular segment as optometrists and general practitioners are better able to screen elderly and diabetic patients for potential retinal disease before referring them to a specialist.

The US market represents more than 43 percent of global market revenues, largely due to lucrative markets for retinal evaluation and the availability of screeners to a large physician population. We anticipate faster growth in emerging markets over the next five years, especially China and India. Growth in these markets will be due largely to expansion of advanced eye care services, resulting from a growing middle class, and general expansion in medical infrastructure to address a largely underserved population.

 

Coming soon

2017 Glaucoma Pharmaceuticals Report: A Global Market Analysis for 2016 to 2022